Einträge von Mancarella, Serena auf dem Publikationsserver

Cigliano, Antonio, Zhang, Shanshan, Ribback, Silvia, Steinmann, Sara, Sini, Marcella, Ament, Cindy E., Utpatel, Kirsten, Song, Xinhua, Wang, Jingxiao , Pilo, Maria G., Berger, Fabian, Wang, Haichuan , Tao, Junyan, Li, Xiaolei, Pes, Giovanni M. , Mancarella, Serena, Giannelli, Gianluigi, Dombrowski, Frank, Evert, Matthias, Calvisi, Diego F., Chen, Xin und Evert, Katja (2022) The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease. Journal of Experimental & Clinical Cancer Research 41, art.no.192.

Mancarella, Serena, Serino, Grazia, Gigante, Isabella, Cigliano, Antonio, Ribback, Silvia, Sanese, Paola , Grossi, Valentina, Simone, Cristiano, Armentano, Raffaele, Evert, Matthias, Calvisi, Diego F. und Giannelli, Gianluigi (2022) CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype. Journal of Experimental & Clinical Cancer Research 41 (1). Volltext nicht vorhanden.

Mancarella, Serena, Gigante, Isabella, Serino, Grazia, Pizzuto, Elena, Dituri, Francesco, Valentini, Maria F., Wang, Jingxiao, Chen, Xin, Armentano, Raffaele, Calvisi, Diego F. und Giannelli, Gianluigi (2022) Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition. Journal of Experimental & Clinical Cancer Research 41 (1). Volltext nicht vorhanden.

Mancarella, Serena, Serino, Grazia, Dituri, Francesco, Cigliano, Antonio , Ribback, Silvia, Wang, Jingxiao, Chen, Xin, Calvisi, Diego F. und Giannelli, Gianluigi (2020) Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis. Cell Death & Differentiation 27 (8), S. 2330-2343. Volltext nicht vorhanden.